<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>25</Volume>
				<Issue>10</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>10</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>The Expression of PDL-1 and PD1 in the Microenvironment of Oral Squamous Cell Carcinoma</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>3471</FirstPage>
			<LastPage>3479</LastPage>
			<ELocationID EIdType="pii">91346</ELocationID>
			
<ELocationID EIdType="doi">10.31557/APJCP.2024.25.10.3471</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Hanan Salman</FirstName>
					<LastName>Wahbi</LastName>
<Affiliation>Department of Oral Pathology, Faculty of Dentistry, Damascus University, Damascus, Syria.</Affiliation>

</Author>
<Author>
					<FirstName>Ahmad Al</FirstName>
					<LastName>Manadili</LastName>
<Affiliation>Department of Oral Pathology, Faculty of Dentistry, Damascus University, Damascus, Syria.</Affiliation>
<Identifier Source="ORCID">0000-0001-5061-2097</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2024</Year>
					<Month>02</Month>
					<Day>16</Day>
				</PubDate>
			</History>
		<Abstract>Objective: Immune checkpoint proteins, especially PD-1/PD-L1, play a vital role in controlling the intensity and duration of the immune response. However, cancer cells often over-expression PDL-1 on their surfaces, which leads to the permanent activation of the PD-1/PDL-1 pathway and exhaustion of T cells and creates a resistant tumor microenvironment. This study aimed to analyze PD-1, PD-L1 expression in tumor cells (PDL-1/TC) and in Tumor-Infiltrating Lymphocytes (PDL-1/TILS) of OSCC patients and associated with and to correlate it with histologic grade of malignancy and clinicopathologic parameters. Methods: The sample consisted of 43 archived specimens of 43 patients of OSCC with Clinical features (gender, age, smoking, clinical stage) collected from medical records between 2014-2021. The intensity of PD-1, PDL-1/TC, PDL-1/TILS, positive cells were assessed by immunohistochemistry. Result: PDL-1/TILS and PDL-1/TC were observed in all specimens except two cases in well-differentiated were negative. PDL-1/TILS was significant between histological grades(P=0.004&lt;0.05). There was no significant between PDL-1/TC and PDL-1/TILS and between poorly differentiated and moderately differentiated groups’ ROC P values (P=0.133, 0.340&gt;0.05) respectively. There is a difference between PDL-1/TC and PDL-1/TILS between poorly differentiated and well-differentiated groups ROC P value (0.005, 0.028), Sensitivity (0.857, 0.857), specificity (0.765, 0.824) respectively and there is a difference between and PDL-1/TILS moderate differentiated and well-differentiated groups ROC P value (0.133,) Sensitivity (0.737), specificity (0.765). No differences between PDL-1/TC and moderate and well-differentiated groups P value (0.173). There is a significant correlation between PDL-1/TC and PDL-1/TILS with an age P&gt;65 value (0.032) in the well-differentiated group. PDL-1/TC and PDL-1/TILS with the depth of invasion (DOI) in the well-differentiated group. No significant correlation was obtained between PDL-1/TC and PDL-1/TILS and smoking, clinical stage, and gender. No significant correlation was obtained between PD1 and the histological grades or clinicopathologic characteristics. Conclusion: PDL-1/TILS and PDL-1/TC are independent prognostic factors in OSCC and PDL1-/TILS has an important role.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">programmed cell death protein 1</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">programmed death ligand 1</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">tumor-infiltrating lymphocytes</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">immune checkpoints</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_91346_c94a7ab13f6d79b0ab6931fe824e7d66.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
